|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL 显示文摘 | Emery J G McDonnell P Burke M B | 1998 | J Biol Chem1998，273，14： | 2 |
| 2 | Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis 显示文摘 | EMERY P GABAY C KRAAN M | 2007 | Rheumatol Int2007，27，9： | 1 |
| 3 | Treatment of rheumatoid arthritis with the selective eostimulation modulator abatacept: twelve-month results of a phase Ⅱ b, double-blind, randomized, placebo-controlled trial显示文摘 | KREMER JM DOUGADOS M EMERY P | 2005 | Arthritis Rheum2005，52，8： | 1 |
| 4 | Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL 显示文摘 | Emery J G Mcdonnell P Burke M B | 1998 | J Biol chem1998，273，14： | 1 |
| 5 | A comparison of the efficacy and safety of leflunomide and methotrexate for the treat- ment of rheumatoid arthritis 显示文摘 | EMERY P BREEDVELD F C LEMMEL E M | 2000 | Rheumatology2000，39，6： | 1 |
| 6 | Treatment of rheumatoid arthritis with the selective costimulation mod-ulator abatacept:twelve-month results of a phase i b, double-blind, randomized, placebo-control ed trial显示文摘 | Kremer JM Dougados M Emery P | | 0，，06： | 1 |
| 7 | The cryb mutation identifies cryptochrome as a circadian photoreceptor in Drosophila显示文摘 | Stanewsky R Kanelp M Emery P | 1998 | Cell1998，95，： | 1 |
| 8 | Treatment of rheumatoid arthritis with the selective costimuiation moculator abatacept:twelve-month results of a phase iib, double-blind, randomized, placebo-contrelled trial 显示文摘 | Kremer JM Dougados M Emery P | 2005 | Arthritis Rheum2005，52，8： | 1 |
| 9 | Patient-reported outcome and quality of life instruments database (PROQOL ID): Frequently asked questions显示文摘 | Emery M P Perrier L L Acquadro C | 2005 | Health Qual Life Outcomes2005，，3： | 1 |
| 10 | Early referral recommendation for newly diagnosed rheumatoid arthritis:evidence based development of a clinical guide 显示文摘 | Emery P Breedveld F C Dougados M | 2002 | Ann Rheum Dis2002，61，4： | 1 |
| 11 | Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy:Results of a multicenter,randomized,double-blind,placebo-controlled,phase Ⅲ trial evaluating primary efficacy and safety at twenty-four weeks显示文摘 | Cohen S B Emery P Greenwald M W | 2006 | Arthritis Rheum2006，54，： | 1 |
| 12 | Thermal infrared observations and thermophysical characterization of OSIRIS-REx target asteroid (101955) Bennu显示文摘 | Emery J P Fernandez Y R Kelley M S P | 2014 | Icarus2014，234，： | 1 |
| 13 | Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy:results of a multicenter,randomized,double-blind,placebo-controlled,phase Ⅲ trial evaluating primary efficacy and safety at twenty-four weeks显示文摘 | Cohen S B Emery P Greenwald M W | 2006 | Arthritis Rheum2006，54，9： | 1 |
| 14 | Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL显示文摘 | Emery J G McDonnell P Burke M B | 1998 | J Biol Chem1998，273，14： | 1 |
| 15 | Apoptosis after traumat- ic human spinal cord injury显示文摘 | Emery E Aldana P Bunge M B | 1998 | J Neurosurg1998，89，： | 1 |
| 16 | Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL显示文摘 | McDonnell P Burke M B | 1998 | J Biol Chem1998，273，14： | 1 |
| 17 | Patient-reported outcome and quality of life instruments database(PROQOLID):frequently asked questions显示文摘 | EMERY M P PERRIER L L AEQUADRO C | 2005 | Health Qual Life Outcomes2005，3，： | 1 |
| 18 | Antigenic and genetic char- acteristics of swine - origin 2009 A( H1N1 ) influenza viruses cir- culating in humans 显示文摘 | Garten R J Davis C T Russell C A Shu B Lindstrom S Balish A Sessions W M Xu X Skepner E Deyde V Okomo - Adhi- ambo M Gubareva L Barnes J Smith C B Emery S L Hillman M J Rivailler P Smagala J de Graaf M Burke D F Fouchier R A Pappas E Alpuche - Aranda C M Lopez - Gatell H Ohvera H Lopez I Myers C A Faix D Blair P J Yu C Keene K M Dotson P D Jr Boxrud D Sambol A R Abid S H St George K Bannerman T Moore A L Stringer D J Blevins P Demmler - Harrison G J Ginsberg M Kriner P Waterman S Smole S Guevara H F Belongia E A Clark P A Beatrice S T Donis R Katz J Finelli L Bridges C B Shaw M Jernigan D B Uyeki T M Smith D J Klimov A I Cox N J | 2009 | Science2009，325，5937： | 1 |
| 19 | Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor, therapy 显示文摘 | Cohen S Emery P Greenwald M | 2006 | Arthritis Rheum2006，54，： | 1 |
| 20 | Competition and salt-marsh plant zonation: Stress tolerators may be dominant competitors显示文摘 | EMERY N C EWANCHUK P J BERTNESS M D | 2001 | Ecology2001，82，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员